Spreadex Market Update

22.04.14 Tuesday Morning



Japanese equities have been put under a little pressure at this early stage in the week, erasing gains in trading. The dollar caught a bid in sympathy of improving prospects for the US economy. The market continues to react sharply to US economic numbers. And investors will scrutinise Chinese manufacturing tomorrow. Supportive earnings news flow yesterday saw the S&P 500 once again a hare’s breadth away from its all-time highs.

 

Trading will resume today in European markets after the Easter break. We’re calling the FTSE 100 up some 25 points ahead of the open at 6,651. One to watch on the open of the London market is AstraZeneca; the global drug maker was caught up in bid talk by US mega-cap Pfizer Inc. over the weekend. ADRs in AZN were trading at a significant premium in Ney York last night, closing up by more than 5 percent.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.